CBUS Long Call Strategy
CBUS (Cibus, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
CBUS (Cibus, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $144.3M, a beta of 1.62 versus the broader market, a 52-week range of 1.09-4.191, average daily share volume of 399K, a public-listing history dating back to 2017, approximately 118 full-time employees. These structural characteristics shape how CBUS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.62 indicates CBUS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on CBUS?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
CBUS snapshot
As of August 14, 2026, spot at $1.78, ATM IV 26.50%, IV rank 2.94%, expected move 7.60%. The long call on CBUS below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on CBUS specifically: CBUS IV at 26.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a CBUS long call, with a market-implied 1-standard-deviation move of approximately 7.60% (roughly $0.14 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CBUS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CBUS should anchor to the underlying notional of $1.78 per share and to the trader's directional view on CBUS stock.
CBUS long call setup
The CBUS long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CBUS at $1.78 on that close, the first option leg uses a $1.78 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CBUS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CBUS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.78 | N/A |
CBUS long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
CBUS long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on CBUS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on CBUS
Long calls on CBUS express a bullish thesis with defined risk; traders use them ahead of CBUS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
CBUS thesis for this long call
The market-implied 1-standard-deviation range for CBUS extends from approximately $1.64 on the downside to $1.92 on the upside. A CBUS long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CBUS IV rank near 2.94% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CBUS at 26.50%. As a Healthcare name, CBUS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CBUS-specific events.
CBUS long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CBUS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CBUS alongside the broader basket even when CBUS-specific fundamentals are unchanged. Long-premium structures like a long call on CBUS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CBUS chain quotes before placing a trade.
Frequently asked questions
- What is a long call on CBUS?
- A long call on CBUS is the long call strategy applied to CBUS (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CBUS stock at $1.78 on the most recent close, the strikes shown on this page are snapped to the nearest listed CBUS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CBUS long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CBUS long call priced from the end-of-day chain at a 30-day expiry (ATM IV 26.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CBUS long call?
- The breakeven for the CBUS long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CBUS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on CBUS?
- Long calls on CBUS express a bullish thesis with defined risk; traders use them ahead of CBUS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current CBUS implied volatility affect this long call?
- CBUS ATM IV is at 26.50% with IV rank near 2.94%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.